| 000 | 01080 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514192612.0 | ||
| 264 | 0 | _c20040930 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a1540-3408 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKang, Elizabeth M | |
| 245 | 0 | 0 |
_aThe leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications. _h[electronic resource] |
| 260 |
_bCurrent hematology reports _cJul 2004 |
||
| 300 |
_a274-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aGenetic Therapy _xadverse effects |
| 650 | 0 | 4 |
_aGenetic Vectors _xadverse effects |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xetiology |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVirus Integration |
| 700 | 1 | _aTisdale, John F | |
| 773 | 0 |
_tCurrent hematology reports _gvol. 3 _gno. 4 _gp. 274-81 |
|
| 999 |
_c14922714 _d14922714 |
||